| Name | Title | Contact Details |
|---|
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.
OB10 is one of the leading providers in Business Services. It is based in Atlanta, GA. To find more information about OB10, please visit www.ob10.com.
Welcome to Italian Citizenship Assistance Program (ICAP), a Division of Bridging Worlds LLC, a US-based program that offers complete services for Italian Dual Citizenship. Established in 2007, we have assisted Americans of Italian descent residing in a...
Distributions Niko Atm Inc is a Saint-Jean-Sur-Richelieu, QC-based company in the Business Services sector.
Shiell and Associates is a Mandeville, LA-based company in the Business Services sector.